Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Ameile
2. Aumolertinib Mesylate
3. Almonertinib (mesylate)
4. Hs-10296 Mesylate
5. Rz6i9wx68u
6. Hs-10296 Methanesulfonate
7. Aumolertinib Mesylate [usan]
8. 2134096-06-1
9. 2-propenamide, N-(5-((4-(1-cyclopropyl-1h-indol-3-yl)-2-pyrimidinyl)amino)-2-((2-(dimethylamino)ethyl)methylamino)-4-methoxyphenyl)-, Compd. With Methanesulfonate (1:1)
10. N-(5-((4-(1-cyclopropyl-1h-indol-3-yl)pyrimidin-2-yl)amino)-2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxyphenyl)acrylamide Methanesulfonate
11. Eq143 Mesylate
12. Eq-143 Mesylate
13. Unii-rz6i9wx68u
14. Almonertinib Mesilate [who-dd]
15. Ex-a6602
16. Hy-112823a
17. Cs-0066156
| Molecular Weight | 621.8 g/mol |
|---|---|
| Molecular Formula | C31H39N7O5S |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 10 |
| Rotatable Bond Count | 11 |
| Exact Mass | 621.27333854 g/mol |
| Monoisotopic Mass | 621.27333854 g/mol |
| Topological Polar Surface Area | 150 Ų |
| Heavy Atom Count | 44 |
| Formal Charge | 0 |
| Complexity | 916 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
ABOUT THIS PAGE
94
PharmaCompass offers a list of Aumolertinib Mesylate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Aumolertinib Mesylate manufacturer or Aumolertinib Mesylate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Aumolertinib Mesylate manufacturer or Aumolertinib Mesylate supplier.
PharmaCompass also assists you with knowing the Aumolertinib Mesylate API Price utilized in the formulation of products. Aumolertinib Mesylate API Price is not always fixed or binding as the Aumolertinib Mesylate Price is obtained through a variety of data sources. The Aumolertinib Mesylate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Almonertinib mesylate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Almonertinib mesylate, including repackagers and relabelers. The FDA regulates Almonertinib mesylate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Almonertinib mesylate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Almonertinib mesylate supplier is an individual or a company that provides Almonertinib mesylate active pharmaceutical ingredient (API) or Almonertinib mesylate finished formulations upon request. The Almonertinib mesylate suppliers may include Almonertinib mesylate API manufacturers, exporters, distributors and traders.
Almonertinib mesylate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Almonertinib mesylate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Almonertinib mesylate GMP manufacturer or Almonertinib mesylate GMP API supplier for your needs.
A Almonertinib mesylate CoA (Certificate of Analysis) is a formal document that attests to Almonertinib mesylate's compliance with Almonertinib mesylate specifications and serves as a tool for batch-level quality control.
Almonertinib mesylate CoA mostly includes findings from lab analyses of a specific batch. For each Almonertinib mesylate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Almonertinib mesylate may be tested according to a variety of international standards, such as European Pharmacopoeia (Almonertinib mesylate EP), Almonertinib mesylate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Almonertinib mesylate USP).
